The Miracle of Stem Cell Therapy for Post-Stroke Patients with Type 2 Diabetes

Authors

  • Deby Susanti Vinski Celltech Stem Cell Centre Laboratory And Banking, Jakarta, Indonesia
  • Natasha Cinta Vinski Celltech Stem Cell Centre Laboratory And Banking, Jakarta, Indonesia

DOI:

https://doi.org/10.58344/jws.v3i1.524

Keywords:

Stroke, Stroke Therapy, Stem Cells, CELLTECH

Abstract

The objective of this research is to explain and analyze the miraculous effectiveness of stem cell therapy in treating post-stroke patients, particularly those with diabetes, and to study the consistent properties of this treatment method. The research method employed is a case study that administered stem cell therapy to five post-stroke patients with diabetes, aged between 53 and 72 years. Patient care records, including evaluations and analyses, serve as the primary data source for this study. The stem cells utilized in the therapy are derived from products cultured by the CELLTECH Stem Cell and Banking Laboratory, with processes undergoing thorough quality reviews. The study demonstrates that stem cells have proven to be capable of repairing damaged cells, especially in post-stroke therapy. Some patients undergoing therapy at the CELLTECH Stem Cell Center have successfully recovered and regained the ability to walk. These results are reinforced by a series of laboratory tests confirming their efficacy. Treatments conducted at the Vinski Regenerative Center also show positive research outcomes, enhancing confidence in the clinic's medical services. The implications of this research suggest that stem cell therapy could be an effective method in treating post-stroke patients with diabetes. The positive outcomes of this research could also bolster public trust in medical services provided by stem cell therapy centers such as CELLTECH Stem Cell Center and Vinski Regenerative Center. Further studies and the development of stem cell therapies may open new possibilities in the treatment of post-stroke and related conditions.

References

Alsbrook, D. L., Di Napoli, M., Bhatia, K., Biller, J., Andalib, S., Hinduja, A., Rodrigues, R., Rodriguez, M., Sabbagh, S. Y., & Selim, M. (2023). Neuroinflammation in acute ischemic and hemorrhagic stroke. Current Neurology and Neuroscience Reports, 23(8), 407–431.

Carcel, C., Woodward, M., Wang, X., Bushnell, C., & Sandset, E. C. (2020). Sex matters in stroke: a review of recent evidence on the differences between women and men. Frontiers in Neuroendocrinology, 59, 100870.

Feske, S. K. (2021). Ischemic stroke. The American Journal of Medicine, 134(12), 1457–1464.

Griffis, J. C., Metcalf, N. V, Corbetta, M., & Shulman, G. L. (2020). Damage to the shortest structural paths between brain regions is associated with disruptions of resting-state functional connectivity after stroke. NeuroImage, 210, 116589.

Guan, J., Wang, G., Wang, J., Zhang, Z., Fu, Y., Cheng, L., Meng, G., Lyu, Y., Zhu, J., & Li, Y. (2022). Chemical reprogramming of human somatic cells to pluripotent stem cells. Nature, 605(7909), 325–331.

Hankey, G. J. (2020). Population impact of potentially modifiable risk factors for stroke. Stroke, 51(3), 719–728.

Joy, M. T., & Carmichael, S. T. (2021). Encouraging an excitable brain state: mechanisms of brain repair in stroke. Nature Reviews Neuroscience, 22(1), 38–53.

Khalil, H. M., & Lahoud, N. (2020). Knowledge of stroke warning signs, risk factors, and response to stroke among Lebanese older adults in Beirut. Journal of Stroke and Cerebrovascular Diseases, 29(5), 104716.

Kimbrel, E. A., & Lanza, R. (2020). Next-generation stem cells—ushering in a new era of cell-based therapies. Nature Reviews Drug Discovery, 19(7), 463–479.

Kuriakose, D., & Xiao, Z. (2020). Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. International Journal of Molecular Sciences. https://doi.org/10.3390/IJMS21207609

Madsen, T. E., Khoury, J. C., Leppert, M., Alwell, K., Moomaw, C. J., Sucharew, H., Woo, D., Ferioli, S., Martini, S., & Adeoye, O. (2020). Temporal trends in stroke incidence over time by sex and age in the GCNKSS. Stroke, 51(4), 1070–1076.

Marini, S., Anderson, C. D., & Rosand, J. (2020). Genetics of cerebral small vessel disease. Stroke, 51(1), 12–20.

Mendelson, S. J., & Prabhakaran, S. (2021). Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review. Jama, 325(11), 1088–1098.

Mizuta, N., Hasui, N., Nakatani, T., Takamura, Y., Fujii, S., Tsutsumi, M., Taguchi, J., & Morioka, S. (2020). Walking characteristics including mild motor paralysis and slow walking speed in post-stroke patients. Scientific Reports, 10(1), 11819.

Murphy, S. J., & Werring, D. J. (2020). Stroke: causes and clinical features. Medicine (Abingdon, England?: UK Ed.). https://doi.org/10.1016/J.MPMED.2020.06.002

Powers, W. J. (2020). Acute ischemic stroke. New England Journal of Medicine, 383(3), 252–260.

Soto-Cámara, R., González-Bernal, J. J., González-Santos, J., Aguilar-Parra, J. M., Trigueros, R., & López-Liria, R. (2020). Knowledge on signs and risk factors in stroke patients. Journal of Clinical Medicine, 9(8), 2557.

Viderman, D., Issanov, A., Temirov, T., Goligher, E., & La Fleur, P. (2020). Outcome predictors of stroke mortality in the neurocritical care unit. Frontiers in Neurology, 11, 579733.

Viedma-Guiard, E., Guidoux, C., Amarenco, P., & Meseguer, E. (2021). Aortic sources of embolism. Frontiers in Neurology, 11, 606663.

Downloads

Published

2024-01-29